Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.1 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |